Our further assessment of basal-like breast cancers suggests that TRPV4 may contribute to or correlate with more invasive disease, given its association with poorer relapse-free survival in LN+ basal breast cancers but not LN-. This evidence concerns the gene TRPV4 and breast carcinoma.